Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-09-19 12:23 pm Purchase | 2025-09-12 | 13G | BioCryst Pharmaceuticals, Inc. BCRX | Deerfield Mgmt, L.P. | 12,169,000 5.800% | 5,793,857 (+90.88%) | Filing History |
| 2025-05-15 09:31 am Sale | 2025-03-31 | 13G | BioCryst Pharmaceuticals, Inc. BCRX | Avoro Capital Advisors LLC | 8,700,000 4.200% | -4,350,000 (-33.33%) | Filing History |
| 2025-04-17 09:35 am Sale | 2025-03-31 | 13G | BioCryst Pharmaceuticals, Inc. BCRX | BlackRock Inc. BLK | 17,483,490 8.400% | -3,558,982 (-16.91%) | Filing History |
| 2024-11-07 10:52 am Purchase | 2024-10-31 | 13G | BioCryst Pharmaceuticals, Inc. BCRX | VANGUARD GROUP INC | 20,730,939 10.020% | 424,343 (+2.09%) | Filing History |
| 2024-11-07 10:25 am Unchanged | 2024-09-30 | 13G | BioCryst Pharmaceuticals, Inc. BCRX | VANGUARD GROUP INC | 20,306,596 9.810% | 0 (Unchanged) | Filing History |
| 2024-11-04 11:18 am Purchase | 2024-09-30 | 13G | BioCryst Pharmaceuticals, Inc. BCRX | VANGUARD GROUP INC | 20,306,596 9.810% | 2,542,876 (+14.31%) | Filing History |
| 2024-10-17 11:52 am Sale | 2024-09-30 | 13G | BioCryst Pharmaceuticals, Inc. BCRX | STATE STREET CORP STT | 8,849,588 4.300% | -3,927,415 (-30.74%) | Filing History |
| 2024-09-10 12:09 pm Purchase | 2024-08-31 | 13G | BioCryst Pharmaceuticals, Inc. BCRX | BlackRock Inc. BLK | 21,042,472 10.200% | 2,361,102 (+12.64%) | Filing History |
| 2024-02-14 4:21 pm Sale | 2023-12-31 | 13G | BioCryst Pharmaceuticals, Inc. BCRX | Baker Bros. Advisors LP | 10,204,089 4.980% | -8,980,705 (-46.81%) | Filing History |
| 2024-02-14 09:02 am Purchase | 2023-12-31 | 13G | BioCryst Pharmaceuticals, Inc. BCRX | Avoro Capital Advisors LLC | 13,050,000 6.400% | 13,050,000 (New Position) | Filing History |
| 2024-02-13 5:00 pm Purchase | 2023-12-29 | 13G | BioCryst Pharmaceuticals, Inc. BCRX | VANGUARD GROUP INC | 17,763,720 8.670% | 3,559,325 (+25.06%) | Filing History |
| 2024-01-24 5:23 pm Purchase | 2023-12-31 | 13G | BioCryst Pharmaceuticals, Inc. BCRX | BlackRock Inc. BLK | 18,681,370 9.100% | 3,762,415 (+25.22%) | Filing History |
| 2024-01-24 1:06 pm Purchase | 2023-12-31 | 13G | BioCryst Pharmaceuticals, Inc. BCRX | STATE STREET CORP STT | 12,777,003 6.240% | 1,650,142 (+14.83%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | BioCryst Pharmaceuticals, Inc. BCRX | Baker Bros. Advisors LP | 19,184,794 9.950% | 720,050 (+3.90%) | Filing History |
| 2023-02-09 11:12 am Purchase | 2022-12-30 | 13G | BioCryst Pharmaceuticals, Inc. BCRX | VANGUARD GROUP INC | 14,204,395 7.620% | 4,791,490 (+50.90%) | Filing History |
| 2023-02-06 09:33 am Purchase | 2022-12-31 | 13G | BioCryst Pharmaceuticals, Inc. BCRX | STATE STREET CORP STT | 11,126,861 5.970% | 2,877,832 (+34.89%) | Filing History |
| 2023-02-03 4:27 pm Purchase | 2022-12-31 | 13G | BioCryst Pharmaceuticals, Inc. BCRX | BlackRock Inc. BLK | 14,918,955 8.000% | 131,560 (+0.89%) | Filing History |
| 2022-02-14 4:15 pm Purchase | 2021-12-31 | 13G | BioCryst Pharmaceuticals, Inc. BCRX | Baker Bros. Advisors LP | 18,464,744 9.950% | 285,863 (+1.57%) | Filing History |
| 2022-02-09 3:33 pm Sale | 2021-12-31 | 13G | BioCryst Pharmaceuticals, Inc. BCRX | VANGUARD GROUP INC | 9,412,905 5.230% | -2,186,429 (-18.85%) | Filing History |
| 2022-02-09 11:33 am Purchase | 2021-12-31 | 13G | BioCryst Pharmaceuticals, Inc. BCRX | STATE STREET CORP STT | 8,249,029 4.580% | 940,213 (+12.86%) | Filing History |